| This article has been cited by |
| 1 | TARDIVE DYSKINESIA AND OTHER EXTRAPYRAMIDAL SYMPTOMS ASSOCIATED WITH ARIPIPRAZOLE: A CASE SERIES | |
| Nayana Sanjay Naik,Yvonne Da Silva Pereira,Prashant Gohil |
| Journal of Evolution of Medical and Dental Sciences.2016;5(50)3229 |
| [DOI] |
|
| 2 | Carbamazepine-, Oxcarbazepine-, Eslicarbazepine-Associated Movement Disorder: A Literature Review | |
| Jamir Pitton Rissardo,Ana Letícia Fornari Caprara |
| Clinical Neuropharmacology.2020;43(3)66 |
| [DOI] |
|
| 3 | Drug-induced tardive dyskinesia | |
| T. M. Ostroumova,V. A. Tolmacheva,O. D. Ostroumova,V. A. Parfenov |
| Neurology, Neuropsychiatry, Psychosomatics.2020;12(1)81 |
| [DOI] |
|
| 4 | Drug-induced tardive dyskinesia | |
| Stephen Thornton,Uttam Garg |
| Neurology, Neuropsychiatry, Psychosomatics.2020;12(1)139 |
| [DOI] |
|
| 5 | The Safety and Tolerability of Newer Antiepileptic Drugs in Children and Adolescents | |
| Saima Kayani,Deepa Sirsi |
| Journal of Central Nervous System Disease.2012;4(1)JCNSD.S5097 |
| [DOI] |
|
| 6 | Movement disorders associated with antiseizure medications: A systematic review | |
| Daniel J. Zhou,Spriha Pavuluri,Isha Snehal,Cynthia M. Schmidt,Miguel Situ-Kcomt,Olga Taraschenko |
| Epilepsy & Behavior.2022;131(1)108693 |
| [DOI] |
|
